Latest news with #ElysiumHealth
Scoop
3 days ago
- Health
- Scoop
Immortality At A Price: How The Promise Of Delaying Death Has Become A Consumer Marketing Bonanza
Article – The Conversation Living forever has become the wellness and marketing trend of the 2020s. But cheating death – or at least delaying it – will come at a price. What was once the domain of scientists and the uber rich is increasingly becoming a consumer product. Those pushing the idea, spearheaded by tech billionaire Bryan Johnson's ' Don't Die ' movement, believe death isn't inevitable, but is a solvable problem. The global longevity market – spanning gene therapies, anti-ageing drugs, diagnostics and wellness plans – is projected to hit US$610 billion this year. At its core, the marketing of these products feeds off the age-old fear of mortality and the desire to stay young. But while the marketing is reaching the masses, this is still very much a luxury product. Immortality is being sold as exclusive, aspirational and symbolic. It's not just about living longer – it's about signalling status, controlling biology and being your 'best future self'. Tapping into long-held fears What's known as ' terror management theory ' puts forward the idea that humans and other animals have an instinctive drive for self-preservation. But humans are not only self-aware, they are also able to anticipate future outcomes – including the inevitability of death. The messaging behind the push to extend life taps into this internal tension between knowledge of our own mortality and the self-preservation instinct. And to be fair, it is not a new phenomenon. Cryonics – the preservation of bodies and brains at extremely low temperatures with the hope medical advancements will allow for their revival at some point in the future – was first popularised in Robert Ettinger's 1962 book The Prospect of Immortality. Since then, the super-rich have invested in various companies promising to preserve their bodies for some unknown future date. It now costs US$200,000 to freeze your body, or $80,000 for just your brain. What's truly new is how death is being marketed – not as fate, but as a flaw. Longevity isn't just about living longer; it's about turning mortality into a design problem, something to delay, manage and eventually solve. 'Biohacking' sells the idea that with the right data, tools and discipline, you can upgrade your biology – and become your best, most future-proof self. This pitch targets high-income consumers aged 30 to 60, people already fluent in the language of optimisation – a mindset focused on maximising performance, productivity and longevity through data. The brands behind the living forever movement sell control, optimisation and elite identity. Ageing becomes a personal failure. Anti-ageing is self-discipline. Consumers are cast as CEOs of their own health – tracking sleep, fixing their gut and taking supplements. From biohacks to consumer branding There are now more than 700 companies working in the longevity market. Startups such as Elysium Health and Human Longevity Inc. offer DNA testing, supplements and personalised health plans. These aren't medical treatments – they're sold as tools to age 'smarter' or 'slower' and are pitched with the language of control over what once might have seemed uncontrollable. Don't Die's Bryan Johnson spends over US$2 million annually on his personal anti-ageing experiment. But the real pitch is to consumers: buy back time, one premium subscription at a time. Johnson's company Blueprint offers diagnostics, supplements and exercise routines bundled into monthly plans starting at $333 and climbing to over $1,600. Longevity products promise more than health. They promise time, control and even immortality. But the quest to live forever, or at least a lot longer, raises moral and ethical questions about who benefits, and what kind of world is being created. Without thoughtful oversight, these technologies risk becoming tools of exclusion, not progress. Because if time becomes a product, not everyone will get to check out at the same counter.
Scoop
3 days ago
- Health
- Scoop
Immortality At A Price: How The Promise Of Delaying Death Has Become A Consumer Marketing Bonanza
Living forever has become the wellness and marketing trend of the 2020s. But cheating death – or at least delaying it – will come at a price. What was once the domain of scientists and the uber rich is increasingly becoming a consumer product. Those pushing the idea, spearheaded by tech billionaire Bryan Johnson's ' Don't Die ' movement, believe death isn't inevitable, but is a solvable problem. The global longevity market – spanning gene therapies, anti-ageing drugs, diagnostics and wellness plans – is projected to hit US$610 billion this year. At its core, the marketing of these products feeds off the age-old fear of mortality and the desire to stay young. But while the marketing is reaching the masses, this is still very much a luxury product. Immortality is being sold as exclusive, aspirational and symbolic. It's not just about living longer – it's about signalling status, controlling biology and being your 'best future self'. Tapping into long-held fears What's known as ' terror management theory ' puts forward the idea that humans and other animals have an instinctive drive for self-preservation. But humans are not only self-aware, they are also able to anticipate future outcomes – including the inevitability of death. The messaging behind the push to extend life taps into this internal tension between knowledge of our own mortality and the self-preservation instinct. And to be fair, it is not a new phenomenon. Cryonics – the preservation of bodies and brains at extremely low temperatures with the hope medical advancements will allow for their revival at some point in the future – was first popularised in Robert Ettinger's 1962 book The Prospect of Immortality. Since then, the super-rich have invested in various companies promising to preserve their bodies for some unknown future date. It now costs US$200,000 to freeze your body, or $80,000 for just your brain. What's truly new is how death is being marketed – not as fate, but as a flaw. Longevity isn't just about living longer; it's about turning mortality into a design problem, something to delay, manage and eventually solve. 'Biohacking' sells the idea that with the right data, tools and discipline, you can upgrade your biology – and become your best, most future-proof self. This pitch targets high-income consumers aged 30 to 60, people already fluent in the language of optimisation – a mindset focused on maximising performance, productivity and longevity through data. The brands behind the living forever movement sell control, optimisation and elite identity. Ageing becomes a personal failure. Anti-ageing is self-discipline. Consumers are cast as CEOs of their own health – tracking sleep, fixing their gut and taking supplements. From biohacks to consumer branding There are now more than 700 companies working in the longevity market. Startups such as Elysium Health and Human Longevity Inc. offer DNA testing, supplements and personalised health plans. These aren't medical treatments – they're sold as tools to age 'smarter' or 'slower' and are pitched with the language of control over what once might have seemed uncontrollable. Don't Die's Bryan Johnson spends over US$2 million annually on his personal anti-ageing experiment. But the real pitch is to consumers: buy back time, one premium subscription at a time. Johnson's company Blueprint offers diagnostics, supplements and exercise routines bundled into monthly plans starting at $333 and climbing to over $1,600. Longevity products promise more than health. They promise time, control and even immortality. But the quest to live forever, or at least a lot longer, raises moral and ethical questions about who benefits, and what kind of world is being created. Without thoughtful oversight, these technologies risk becoming tools of exclusion, not progress. Because if time becomes a product, not everyone will get to check out at the same counter.
Yahoo
13-03-2025
- Health
- Yahoo
Elysium Health™ Announces the Launch of COFACTOR™: An advanced 4-in-1 Collagen System With NAD+ Boost
The first and only product formulated to increase collagen production by addressing multiple root causes of aging and collagen decline NEW YORK, March 13, 2025 /PRNewswire/ -- Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced the launch of COFACTOR™ by Elysium Health, a first-of-its-kind, proven collagen supplement that delivers complete support by providing the building blocks to increase collagen production and by addressing multiple root causes of collagen decline—aged fibroblasts, decline in NAD+, and decline in hyaluronic acid (HA). Developed by the experts in aging, Cofactor targets the most critical cellular components associated with the age-related loss of collagen. Its unique formulation combines grass-fed collagen peptides with the clinically proven NAD+ booster nicotinamide riboside (NR), hyaluronic acid (HA), and the essential collagen cofactor vitamin C, which together make up its 4-in-1 system. Working throughout the body, the ingredients in Cofactor are clinically proven to significantly improve skin texture, wrinkles, dermal density (a reflection of the amount of structural components like collagen and elastin), and moisture for a more youthful appearance, as well as support resilient joints, healthy bones, and hair and nail health. With age, the number of fibroblasts (cells that produce collagen) goes down. Moreover, the remaining fibroblasts produce less collagen. While supplementing with collagen alone provides some clinical benefit, addressing multiple root causes of aging in the collagen system—fibroblasts, NAD+, and HA—is a far more comprehensive and powerful approach. Research has repeatedly demonstrated the cellular health benefits of restoring NAD+ to youthful levels. Preclinical evidence also shows that aged fibroblasts treated with NAD+ precursors produce more collagen—like more youthful fibroblasts. Cofactor's 4-in-1 system takes a complete cellular approach to supporting collagen, the body's most abundant protein. "The global collagen market is projected to reach $14.4 billion by 2033, driven by rising health awareness, increasing demand for functional foods and supplements, and interest in skin care and joint health products," said Elysium Health CEO Eric Marcotulli. "Even so, we were unable to identify any available products that address key drivers of collagen decline, including aging. We developed Cofactor to offer a comprehensive solution—addressing several root causes of aging that impact collagen synthesis, loss, and degradation." With age, levels of NAD+, collagen, and HA all go down. By age 40, collagen levels have dropped by about 25%, and the decline of NAD+ is a hallmark feature of aging. In skin, NAD+ levels decrease by almost 60% between young adulthood and middle age, impacting the health and function of the cells that produce collagen as well as other components necessary for maintaining skin health and structure. HA is critical to the health of the extracellular matrix, which surrounds and supports cells and tissues in the body. Its decline impacts collagen production and maintenance. Cofactor is designed to restore all three molecules: Grass-fed collagen peptides provide the building blocks and stimulus for collagen production, and vitamin C functions as an essential cofactor for collagen synthesis, providing proven health benefits for skin, hair, nails, bones, and joints NR is clinically proven to raise NAD+ to youthful levels, which creates a youthful cellular environment for collagen and ceramide synthesis and helps to combat collagen degradation Oral HA increases levels of HA throughout the extracellular matrix of the skin and further supports a youthful cellular environment for collagen production and maintenance, improving skin elasticity, hydration, and barrier function "The four ingredients in Cofactor's unique formulation are designed to work synergistically," said Elysium Health chief scientist and Novartis Professor of Biology at MIT Leonard Guarente, Ph.D. "NAD+ to combat aging and promote cellular health, collagen peptides for collagen support, HA for moisture, and vitamin C to aid collagen synthesis." About Elysium Health™Elysium Health's™ mission is to solve the biggest challenges in health with science, to help people lead healthier lives. Working directly with the world's leading scientists and clinicians, Elysium Health™ is committed to translating critical advancements in aging research into health solutions people can access today. Learn more at View original content to download multimedia: SOURCE Elysium Health Sign in to access your portfolio
